---
title: "Entropy-Based Framework to Quantify Dynamic Epistemic Uncertainty in Clinical LLM Reasoning"
id: "medrxiv-1-novel-entropy-based-framework-for-quantifying-dynamic-epistemic-uncertainty-in"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-1-novel-entropy-based-framework-for-quantifying-dynamic-epistemic-uncertainty-in"
content_type: "clinical_feed_article"
specialty: "Critical Care"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.27.26361497v1?rss=1"
published_at: "2026-08-31T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Entropy-Based Framework to Quantify Dynamic Epistemic Uncertainty in Clinical LLM Reasoning
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-1-novel-entropy-based-framework-for-quantifying-dynamic-epistemic-uncertainty-in
- **Specialty:** [Critical Care](https://medichelpline.com/clinical-feed/critical-care.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.27.26361497v1?rss=1)
- **Published At:** 2026-08-31T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The paper introduces a closed-loop, multi-agent framework that quantifies and visualizes **dynamic epistemic uncertainty** in clinical large language model (LLM) reasoning by coupling predictive **Shannon entropy** with non-linear Isometric Feature Mapping (**ISOMAP**). - High-dimensional inference state vectors are projected to a calibrated two-dimensional latent space to assign a thermodynamic-like energy state to reasoning trajectories, enabling tracking of diagnostic velocity, cognitive momentum, and trajectory efficiency across sequential diagnostic rounds. - The framework is designed to address limitations of current interpretability approaches (latent space trajectories, Concept Activation Vectors, Concept Bottleneck Models), which the authors say suffer from topological stagnation, metric distortion, and epistemic occlusion that can conceal intermediate uncertainty behind overconfident outputs. - Pilot validation used representative emergency medicine scenarios and identified distinct topological and information-theoretic behaviors: unconfounded cerebellar infarction cases showed smooth geodesic progression and monotonic entropy decay from 2.15 to 1.74; spontaneous pneumothorax cases in noisy environments displayed trajectory wandering, local minima traps, and sustained high entropy (~2.41); acute cholangitis triage-conflicted cases reached geometric proximity to the true node but had top-1 rank stagnation due to conflation of severity (sepsis) and anatomical etiology. - The visualized trajectories and entropy measures aim to render machine hesitation and cognitive divergence auditable prior to final outputs, supporting dynamic trust calibration and human–AI co-regulation at the point of care. - The authors propose this geometric-information foundation could enable architectural interventions such as dual-channel safety decoupling and non-linear repulsive weighting; they state that validating these enhancements across large EHR databases and prospective clinical trials is necessary for clinical utility. - The framework as described also seeks to capture and externalize clinician cognitive patterns within the AI, creating coupled visualizations of physician hypotheses and AI inferences to reduce diagnostic oversight while preserving human responsibility for final decisions. - Competing interests are disclosed: joint research funding from SoftBank Corp. to one author; four authors are full-time employees of SoftBank Corp.; remaining authors report no competing financial interests. Data are available on reasonable request to the authors.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=ZE2uwB0q2odJKFAsYP.AcGvzMQUu1o_1S7M7VixCPl8-1788231025.8975537-1.2.1.1-7KT1D2EoGotjkrqjc12QmBqh3mXpnSvfpMX0w9k4kMUIjQEEoDvDjWyU7yCpEdxX) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.08.27.26361497v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Novel Entropy-Based Framework for Quantifying Dynamic Epistemic Uncertainty in Clinical Medicine Yuichiro Yano, Eigo Shintani, Shunya Arita, Rei Ashine, Naoaki Iinuma, Hirotake Mori, Kazutoshi Fujibayashi, Yosuke Yamada, Mizue Saita, Naoki Nakashima, Hiroshi Itoh, Masaomi Nangaku, Mizuki Ohashi, Hiroyuki Daida, Hajime Arai, Toshio Naito doi: https://doi.org/10.64898/2026.08.27.26361497 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Yuichiro Yano 1 Juntendo University Faculty of Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Yuichiro%2BYano%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Yano%20Y&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AYuichiro%2BYano%2B) * For correspondence: y.yano@juntendo.ac.jp Eigo Shintani 2 SoftBank Corp.; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Eigo%2BShintani%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Shintani%20E&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AEigo%2BShintani%2B) Shunya Arita 2 SoftBank Corp.; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Shunya%2BArita%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Arita%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AShunya%2BArita%2B) Rei Ashine 2 SoftBank Corp.; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Rei%2BAshine%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Ashine%20R&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ARei%2BAshine%2B) Naoaki Iinuma 2 SoftBank Corp.; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Naoaki%2BIinuma%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Iinuma%20N&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ANaoaki%2BIinuma%2B) Hirotake Mori 1 Juntendo University Faculty of Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Hirotake%2BMori%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Mori%20H&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AHirotake%2BMori%2B) Kazutoshi Fujibayashi 1 Juntendo University Faculty of Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Kazutoshi%2BFujibayashi%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Fujibayashi%20K&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AKazutoshi%2BFujibayashi%2B) Yosuke Yamada 1 Juntendo University Faculty of Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Yosuke%2BYamada%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Yamada%20Y&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AYosuke%2BYamada%2B) Mizue Saita 1 Juntendo University Faculty of Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Mizue%2BSaita%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Saita%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMizue%2BSaita%2B) Naoki Nakashima 3 Kyushu University Hospital; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Naoki%2BNakashima%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Nakashima%20N&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ANaoki%2BNakashima%2B) Hiroshi Itoh 4 Keio University School of Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Hiroshi%2BItoh%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Itoh%20H&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AHiroshi%2BItoh%2B) Masaomi Nangaku 5 The University of Tokyo Graduate School of Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Masaomi%2BNangaku%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Nangaku%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMasaomi%2BNangaku%2B) Mizuki Ohashi 1 Juntendo University Faculty of Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Mizuki%2BOhashi%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Ohashi%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMizuki%2BOhashi%2B) Hiroyuki Daida 6 Juntendo University Graduate School of Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Hiroyuki%2BDaida%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Daida%20H&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AHiroyuki%2BDaida%2B) Hajime Arai 7 Juntendo University * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Hajime%2BArai%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Arai%20H&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AHajime%2BArai%2B) Toshio Naito 1 Juntendo University Faculty of Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Toshio%2BNaito%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Naito%20T&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AToshio%2BNaito%2B) * [Abstract](https://www.medrxiv.org/content/10.64898/2026.08.27.26361497v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1289359/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.08.27.26361497v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1289359/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.08.27.26361497v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1289359/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.08.27.26361497v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1289359/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.08.27.26361497v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1289359/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract The widespread adoption of clinical large language models (LLMs) introduces significant risks of automation bias, premature closure, and clinician deskilling. Current interpretability paradigms, including latent space trajectories, Concept Activation Vectors, and Concept Bottleneck Models, suffer from topological stagnation, metric distortion, and epistemic occlusion, frequently masking intermediate diagnostic uncertainty behind falsely confident outputs. To address these structural vulnerabilities, this paper introduces a novel closed-loop, multi-agent framework designed to quantify and visualize dynamic epistemic uncertainty in clinical LLM reasoning. By coupling predictive Shannon entropy with non-linear Isometric Feature Mapping (ISOMAP), the architecture projects high-dimensional inference state vectors onto a calibrated two-dimensional latent space, thereby assigning a quantifiable thermodynamic energy state to the reasoning path to track diagnostic velocity, cognitive momentum, and trajectory efficiency across sequential diagnostic rounds. Pilot validation across representative emergency medicine scenarios demonstrated distinct topological and information-theoretic behaviors: unconfounded cases (cerebellar infarction) exhibited smooth geodesic progression toward the ground truth alongside monotonic Shannon entropy decay from 2.15 to 1.74; noisy environments with ambiguous findings (spontaneous pneumothorax) suffered from trajectory wandering, local minimum traps, and high sustained entropy (~2.41) due to insufficient repulsive weighting for negative evidence; and triage-conflicted cases (acute cholangitis) achieved precise geometric proximity to the true node but experienced top-1 rank stagnation because the model conflated acute severity triage (sepsis) with anatomical etiology. By rendering machine hesitation and cognitive divergence visually auditable before final diagnostic crystallization, this geometric-information framework enables dynamic trust calibration and human-AI co-regulation at the point of care while establishing a clear mathematical foundation for future architectural interventions, such as dual-channel safety decoupling and non-linear repulsive weighting. Moving forward, validating these architectural enhancements across large-scale electronic health record databases and prospective clinical trials will be essential to realize its full clinical utility, establishing a foundational blueprint for safe, transparent, and cognitively synergistic AI integration in future medical practice. By rendering the LLM's reasoning process visually auditable, this framework lays the groundwork for capturing and externalizing the clinician's own cognitive patterns within the AI, forming a coupled system. This enables the explicit visualization of cognitive gaps between physician hypotheses and AI inferences, transforming the interaction from simple answer-checking into a dynamic learning process for both human and machine that prevents diagnostic oversight. Ultimately, because the responsibility for final clinical decision-making remains with the human practitioner, this framework serves as a vital decision-support mechanism. Moving forward, validating these architectural enhancements across large-scale electronic health record databases and prospective clinical trials will be essential to realize its full clinical utility, establishing a foundational blueprint for safe, transparent, and cognitively synergistic AI integration in future medical practice. ### Competing Interest Statement Yuichiro Yano reports receiving joint research funding from SoftBank Corp. Eigo Shintani, Shunya Arita, Rei Ashine, and Naoaki Iinuma are full-time employees of SoftBank Corp., a company actively engaged in the development of commercial and domain-specific large language models (LLMs). The remaining authors declare no competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability All data produced in the present study are available upon reasonable request to the authors ## Funder Information Declared SoftBank Corp. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC-ND 4.0 International license](http://creativecommons.org/licenses/by-nc-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.08.27.26361497v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.08.27.26361318v1 "Assessing hospital workers′ health: a tool for longitudinal health monitoring in a public tertiary hospital in Brazil′s Unified Health System \(SUS\)")[Next ](https://www.medrxiv.org/content/10.64898/2026.08.29.26361405v1 "Evaluation of risk stratification at presentation using the Alinity high-sensitivity cardiac troponin I assay") Posted August 31, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.08.27.26361497v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/08/31/2026.08.27.26361497.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.08.27.26361497v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/08/31/2026.08.27.26361497.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Novel Entropy-Based Framework for Quantifying Dynamic Epistemic Uncertainty in Clinical Medicine Yuichiro Yano, Eigo Shintani, Shunya Arita, Rei Ashine, Naoaki Iinuma, Hirotake Mori, Kazutoshi Fujibayashi, Yosuke Yamada, Mizue Saita, Naoki Nakashima, Hiroshi Itoh, Masaomi Nangaku, Mizuki Ohashi, Hiroyuki Daida, Hajime Arai, Toshio Naito medRxiv 2026.08.27.26361497; doi: https://doi.org/10.64898/2026.08.27.26361497 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.27.26361497v1%26text%3DNovel%2520Entropy-Based%2520Framework%2520for%2520Quantifying%2520Dynamic%2520Epistemic%2520Uncertainty%2520in%2520Clinical%2520Medicine "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.27.26361497v1%26t%3DNovel%2520Entropy-Based%2520Framework%2520for%2520Quantifying%2520Dynamic%2520Epistemic%2520Uncertainty%2520in%2520Clinical%2520Medicine "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.27.26361497v1%26title%3DNovel%2520Entropy-Based%2520Framework%2520for%2520Quantifying%2520Dynamic%2520Epistemic%2520Uncertainty%2520in%2520Clinical%2520Medicine%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.27.26361497v1%26title%3DNovel%2520Entropy-Based%2520Framework%2520for%2520Quantifying%2520Dynami
## Related Clinical Research

- [Therapeutic coma in non‑convulsive status epilepticus: higher complications, longer ICU stay, and](https://medichelpline.com/clinical-feed/pubmed-42701136.md) (DOI: 10.1007/s00415-026-14090-8)
- [ePWV and delirium risk in ICU sepsis patients: retrospective MIMIC-IV analysis and predictive model](https://medichelpline.com/clinical-feed/pubmed-42700537.md) (DOI: 10.1016/j.clinsp.2026.101106)
- [Low‑Dose Epirubicin in Sepsis and Septic Shock: Phase IIa EPOS‑1 Safety and Dose‑Escalation Results](https://medichelpline.com/clinical-feed/medrxiv-1-epirubicin-for-the-treatment-of-sepsis-and-septic-shock-epos-1-a-randomized.md)
- [Offline Reinforcement Learning for Out-of-Distribution ICU Sepsis Decision Support](https://medichelpline.com/clinical-feed/medrxiv-0-offline-reinforcement-learning-for-out-of-distribution-icu-sepsis-decision.md)
- [High AUROC can hide threshold failure in sepsis transcriptomic classifiers: preprocessing stabilit](https://medichelpline.com/clinical-feed/plos-one-13-high-auroc-can-mask-decision-failure-in-sepsis-transcriptomic-classifiers.md)

## Navigation
- [← Back to Critical Care Feed](https://medichelpline.com/clinical-feed/critical-care.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.